Aniracetam is a synthetic nootropic peptide that belongs to the racetam family of compounds. It was first synthesized in the 1970s by Hoffmann-La Roche and has been used primarily in Europe as a cognitive enhancer and anxiolytic. Aniracetam is thought to work by modulating the activity of specific neurotransmitters in the brain, such as acetylcholine and glutamate.
Aniracetam is structurally similar to piracetam, the first racetam compound to be synthesized, but it is considered to be more potent and have a faster onset of action. It is fat-soluble and can be taken orally, with effects typically reported within 45 minutes to an hour after dosing.
Aniracetam is thought to enhance cognitive function by increasing the release of acetylcholine, a neurotransmitter that is critical for memory and learning. It is also thought to modulate the activity of AMPA receptors, which are involved in the regulation of neuronal excitability and synaptic plasticity. These mechanisms of action may underlie the cognitive-enhancing effects of aniracetam, including improved memory, attention, and overall cognitive function.
Aniracetam also has anxiolytic properties, and it is thought to work by modulating the activity of the GABAergic and serotonergic systems in the brain. It is also thought to have anti-depressant and anti-anxiety effects.
In addition to its cognitive and anxiolytic effects, aniracetam is also thought to have neuroprotective properties. It has been shown to protect against neurotoxicity induced by a variety of agents, including ischemia, hypoxia, and excitotoxicity. It is also thought to have anti-inflammatory effects and to be beneficial in the treatment of neurodegenerative disorders such as Alzheimer’s disease.
Aniracetam is considered to be well-tolerated with few side effects. The most commonly reported side effects include headache, insomnia, and gastrointestinal upset. Aniracetam is considered to be non-toxic and non-addictive.
Aniracetam is not approved for use in the United States, but it is available as a dietary supplement. It is also available in some European countries as a prescription medication. The recommended dosage of aniracetam is 750-1500mg per day, taken in two or three divided doses.
Overall, Aniracetam is a nootropic peptide that is thought to enhance cognitive function and reduce anxiety. It is considered to be well-tolerated with few side effects and has a good safety profile. Its mechanism of action is thought to involve the modulation of acetylcholine and AMPA receptors in the brain, which underlie its cognitive-enhancing effects. Aniracetam is also thought to have neuroprotective properties and to be beneficial in the treatment of neurodegenerative disorders. However, it is not approved by FDA and more research is needed to confirm its efficacy and safety.